Phototherapy: Theory and practice.
Journal
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
ISSN: 1610-0387
Titre abrégé: J Dtsch Dermatol Ges
Pays: Germany
ID NLM: 101164708
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
received:
09
11
2022
accepted:
12
04
2023
medline:
15
8
2023
pubmed:
24
7
2023
entrez:
24
7
2023
Statut:
ppublish
Résumé
Despite the development of highly effective biologics for skin diseases such as psoriasis or atopic dermatitis, UVA and UVB therapy, alone or in combination, are still essential components of various guidelines. Phototherapy is not only a first-line treatment and highly effective for a number of skin diseases, but is also economical and has few side effects. The targeted use of UVA and UVB, if necessary, in combination with the photosensitizer psoralen in the context of PUVA therapy, enables the dermatologist to effectively treat a wide variety of skin diseases. Indications for phototherapy include epidermal diseases such as atopic dermatitis, psoriasis and vitiligo, as well as photodermatoses, mycosis fungoides, graft-versus-host disease and deep dermal diseases such as scleroderma. This article reviews the physical principles, molecular mechanisms, current treatment regimens, and individual indications for phototherapy and photochemotherapy.
Types de publication
Review
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
882-897Informations de copyright
© 2023 The Authors. Journal der Deutschen Dermatologischen Gesellschaft published by John Wiley & Sons Ltd on behalf of Deutsche Dermatologische Gesellschaft.
Références
Grzybowski A, Sak J, Pawlikowski J. A brief report on the history of phototherapy. Clin Dermatol. 2016;34(5):532-537.
Finsen N, Forchhammer H. Resultate der Lichtbehandlung bei unseren ersten 800 Fällen von Lupus vulgaris.[Results of light therapy in our first 800 cases of lupus vulgaris]. Mitt Fins Med Lichtinst. 1904;5(6):1-48.
Hönigsmann H. History of phototherapy in dermatology. Photochem Photobiol Sci. 2012;12:16-21.
Parrish JA, Fitzpatrick TB, Tanenbaum L, Pathak MA. Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. N Engl J Med. 1974;291(23):1207-1211.
Housman TS, Rohrback JM, Fleischer AB, Feldman SR. Phototherapy utilization for psoriasis is declining in the United States. J Am Acad Dermatol. 2002;46(4):557-559.
Tan SY, Buzney E, Mostaghimi A. Trends in phototherapy utilization among Medicare beneficiaries in the United States, 2000 to 2015. J Am Acad Dermatol. 2018;79(4):672-679.
Goyal K, Nguyen MO, Reynolds RV, et al. Perceptions of US dermatology residency program directors regarding the adequacy of phototherapy training during residency. Photodermatol Photoimmunol Photomed. 2017;33(6):321-325.
Anderson KL, Huang KE, Huang WW, Feldman SR. Training for prescribing in-office and home phototherapy. Photodermatol Photoimmunol Photomed. 2015;31(6):325-332.
Danesh MJ, Butler DC, Beroukhim K, et al. A cross-sectional survey study to evaluate phototherapy training in dermatology residency. Photodermatol Photoimmunol Photomed. 2015;31(5):269-270.
Augustin M, Girbig G, Hertl M, et al. Status quo und Perspektiven der Hautkliniken in Deutschland: Versorgungsspektren und Personalsituation. J Dtsch Dermatol Ges. 2021;19(S5):14-24.
Kurz B, Ivanova I, Bäumler W, Berneburg M. Turn the light on photosensitivity. J Photochem Photobiol. 2021;8:100071.
Gueymard CA. Parameterized transmittance model for direct beam and circumsolar spectral irradiance. Solar Energy. 2001;71(5):325-346.
Zou Z, Ye J, Sayama K, Arakawa H. Direct splitting of water under visible light irradiation with an oxide semiconductor photocatalyst. Nature. 2001;414(6864):625-627.
Wondrak GT, Jacobson MK, Jacobson EL. Endogenous UVA-photosensitizers: mediators of skin photodamage and novel targets for skin photoprotection. Photochem Photobiol Sci. 2006;5(2):215-237.
Arndt S, Lissner C, Unger P, et al. Biological effects of a new ultraviolet A1 prototype based on light-emitting diodes on the treatment of localized scleroderma. Exp Dermatol. 2020;29(12):1199-1208.
Bormann M, Alt M, Schipper L, et al. Disinfection of SARS-CoV-2 contaminated surfaces of personal items with UVC-LED disinfection boxes. Viruses. 2021;13(4):598.
Kalajian TA, Aldoukhi A, Veronikis AJ, et al. Ultraviolet B light emitting diodes (LEDs) are more efficient and effective in producing vitamin D3 in human skin compared to natural sunlight. Sci Rep. 2017;7(1):11489.
Bäumler W. Singlet oxygen in the skin. In: Singlet Oxygen. 2016:205-226.
Bäumler W, Regensburger J, Knak A, et al. UVA and endogenous photosensitizers - the detection of singlet oxygen by its luminescence. Photochem Photobiol Sci. 2012;11(1):107-117.
Knak A, Regensburger J, Maisch T, Bäumler W. Exposure of vitamins to UVB and UVA radiation generates singlet oxygen. Photochem Photobiol Sci. 2014;13(5):820-829.
Hofmann GA, Weber B. Drug-induced photosensitivity: culprit drugs, potential mechanisms and clinical consequences. J Dtsch Dermatol Ges. 2021;19(1):19-29.
Lankerani L, Baron ED. Photosensitivity to exogenous agents. J Cutan Med Surg. 2004;8(6):424-431.
Finlayson L, Barnard IRM, McMillan L, et al. Depth penetration of light into skin as a function of wavelength from 200 to 1000 nm. Photochem Photobiol. 2022;98(4):974-981.
Singer S, Berneburg M. Phototherapie. J Dtsch Dermatol Ges. 2018;16(9):1120-1131.
Cadet J, Voituriez L, Nardin R, et al. A new class of psoralen photoadducts to DNA components: Isolation and characterization of 8-MOP adducts to the osidic moiety of 2′-deoxyadenosine. J Photochem Photobiol B. 1988;2(3):321-339.
Singer S, Schwarz T, Berneburg M. Grundlagen zur Phototherapie. In: Phototherapie, Springer, 2016:1-7.
Regensburger J, Knak A, Maisch T, et al. Fatty acids and vitamins generate singlet oxygen under UVB irradiation. Exp Dermatol. 2012;21(2):135-139.
Von Thaler AK, Kamenisch Y, Berneburg M. The role of ultraviolet radiation in melanomagenesis. Exp Dermatol. 2010;19(2):81-88.
Morita A, Werfel T, Stege H, et al. Evidence that singlet oxygen-induced human T helper cell apoptosis is the basic mechanism of ultraviolet-A radiation phototherapy. J Exp Med. 1997;186(10):1763-1768.
Berneburg M, Grether-Beck S, Kürten V, et al. Singlet oxygen mediates the UVA-induced generation of the photoaging-associated mitochondrial common deletion. J Biol Chem. 1999;274(22):15345-15349.
Tyrrell RM. Role for singlet oxygen in biological effects of ultraviolet A radiation. Methods Enzymol. 2000;319:290-296
Tewari A, Sarkany RP, Young AR. UVA1 induces cyclobutane pyrimidine dimers but not 6-4 photoproducts in human skin in vivo. J Invest Dermatol. 2012;132(2):394-400.
Douki T, Sage E. Dewar valence isomers, the third type of environmentally relevant DNA photoproducts induced by solar radiation. Photochem Photobiol Sci. 2016;15(1):24-30.
Vieyra-Garcia PA, Wolf P. A deep dive into UV-based phototherapy: Mechanisms of action and emerging molecular targets in inflammation and cancer. Pharmacol Ther. 2021;222:107784.
Goulden V, Ling TC, Babakinejad P, et al. British Association of Dermatologists and British Photodermatology Group guidelines for narrowband ultraviolet B phototherapy 2022. Br J Dermatol. 2022;187(3):295-308.
Herzinger T, Berneburg M, Ghoreschi K, et al. S1-Guidelines on UV phototherapy and photochemotherapy. J Dtsch Dermatol Ges. 2016;14(8): 853-76.
Elmets CA, Lim HW, Stoff B, et al. Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy. J Am Acad Dermatol. 2019;81(3):775-804.
Zhang M, Goyert G, Lim HW. Folate and phototherapy: What should we inform our patients? J Am Acad Dermatol. 2017;77(5):958-964.
Parrish JA, Jaenicke KF. Action spectrum for phototherapy of psoriasis. J Invest Dermatol. 1981;76(5):359-362.
Stege H, Ghoreschi K, Hünefeld C. UV-Phototherapie. Der Hautarzt. 2021;72(1):14-26.
Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol. 1988;124(6):869-871.
Gambichler T, Majert J, Pljakic A, et al. Determination of the minimal erythema dose for ultraviolet A1 radiation. Br J Dermatol. 2017;177(1):238-244.
Krutmann J, Diepgen TL, Luger TA, et al. High-dose UVA1 therapy for atopic dermatitis: results of a multicenter trial. J Am Acad Dermatol. 1998;38(4):589-593.
Krutmann J, Czech W, Diepgen T, et al. High-dose UVA1 therapy in the treatment of patients with atopic dermatitis. J Am Acad Dermatol. 1992;26(2):225-230.
Krutmann J, Hönigsmann H. Handbuch der dermatologischen Phototherapie und Photodiagnostik. Springer-Verlag, 2013.
Werfel T, Heratizadeh A, Aberer W, et al. S2k-Leitlinie Neurodermitis (atopisches Ekzem, atopische Dermatitis) - Kurzversion. Allergo J. 2016;25(3):36-51.
Abeck D, Schmidt T, Fesq H, et al. Long-term efficacy of medium-dose UVA1 phototherapy in atopic dermatitis. J Am Acad Dermatol. 2000;42(2):254-257.
Ben Mordehai Y, Barzilai A, Dalal A, Pavlotsky F. Long-term narrowband UV-B efficacy in moderate to severe atopic dermatitis. Dermatitis. 2022;33(4):282-286.
Rossi M, Rovati C, Arisi M, et al. A short cycle of narrow-band UVB phototherapy in the early phase of dupilumab therapy can provide a quicker improvement of severe atopic dermatitis. Dermatology. 2021;237(3):407-415.
Wollenberg A, Barbarot S, Bieber T, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018;32(5):657-682.
Dayal S, Pathak K, Sahu P, Jain VK. Narrowband UV-B phototherapy in childhood atopic dermatitis: efficacy and safety. An Bras Dermatol. 2017;92:801-806.
Nast A, Altenburg A, Augustin M, et al. Deutsche S3-Leitlinie zur Therapie der Psoriasis vulgaris, adaptiert von EuroGuiDerm - Teil 1: Therapieziele und Therapieempfehlungen. J Dtsch Dermatol Ges. 2021;19(6):934-951.
Hofer A, Fink-Puches R, Kerl H, et al. Paired comparison of bathwater versus oral delivery of 8-methoxypsoralen in psoralen plus ultraviolet: A therapy for chronic palmoplantar psoriasis. Photodermatol Photoimmunol Photomed. 2006;22(1):1-5.
Berneburg M, Brod C, Benedix F, Röcken M. New and established indications for phototherapy with narrowband UVB. J Dtsch Dermatol Ges. 2005;3(11):874-882.
Berneburg M, Röcken M, Benedix R. Phototherapy with narrowband UVB. Acta Derm Venereol. 2005;85:1-11.
Noe MH, Wan MT, Shin DB, et al. Patient-reported outcomes of adalimumab, phototherapy, and placebo in the Vascular Inflammation in Psoriasis Trial: A randomized controlled study. J Am Acad Dermatol. 2019;81(4):923-930.
Marsche G, Holzer M, Wolf P. Antipsoriatic treatment extends beyond the skin: recovering of high-density lipoprotein function. Exp Dermatol. 2014;23(10):701-704.
Vieyra-Garcia PA, Wolf P. Extracorporeal photopheresis: a case of immunotherapy ahead of its time. Transfus Med Hemother. 2020;47(3):226-235.
Ling T, Clayton T, Crawley J, et al. British Association of Dermatologists and British Photodermatology Group guidelines for the safe and effective use of psoralen-ultraviolet A therapy 2015. Br J Dermatol. 2016;174(1):24-55.
Bilsland D, George S, Gibbs N, et al. A comparison of narrow band phototherapy (TL-01) and photochemotherapy (PUVA) in the management of polymorphic light eruption. Br J Dermatol. 1993;129(6):708-712.
Man I, Dawe R, Ferguson J. Artificial hardening for polymorphic light eruption: practical points from ten years' experience. Photodermatol Photoimmunol Photomed. 1999;15(3-4):96-99.
Mastalier U, Kerl H, Wolf P. Clinical, laboratory, phototest and phototherapy findings in polymorphic light eruptions: a retrospective study of 133 patients. Eur J Dermatol. 1999;8(8):554-559.
Gong Y-Y, Rong W, Li L, et al. Successful treatment of polymorphic light eruption with UVA rush hardening: A report of 5 cases. Photodermatol Photoimmunol Photomed. 2020;36(4):322-323.
Beissert S, Ständer H, Schwarz T. UVA rush hardening for the treatment of solar urticaria. J Am Acad Dermatol. 2000;42(6):1030-1032.
Pattamadilok B, Poomputsar T. A retrospective, descriptive study of patients with Mycosis fungoides treated by phototherapy (oral PUVA, NB-UVB) with a twice-weekly regimen at the Institute of Dermatology, Bangkok, Thailand, with an experiential timeline of 13 years. Photodermatol Photoimmunol Photomed. 2021;37(1):49-55.
Vieyra-Garcia P, Fink-Puches R, Porkert S, et al. Evaluation of low-dose, low-frequency oral psoralen - UV-A treatment with or without maintenance on early-stage mycosis fungoides: a randomized clinical trial. JAMA Dermatology. 2019;155(5):538-547.
Adışen E, Tektaş V, Erduran F, et al. Ultraviolet A1 phototherapy in the treatment of early mycosis fungoides. Dermatology. 2017;233(2-3):192-198.
Trovato E, Pellegrino M, Filippi F, et al. Clinical and histological evaluation in patients with mycosis fungoides treated with UVA1. G Ital Dermatol Venereol. 2020;155(3):306-311.
Böhm M, Schunter JA, Fritz K, et al. S1 Guideline: Diagnosis and therapy of vitiligo. J Dtsch Dermatol Ges. 2022;20(3):365-378.
Bae JM, Jung HM, Hong BY, et al. Phototherapy for vitiligo: a systematic review and meta-analysis. JAMA Dermatol. 2017;153(7):666-674.
Batchelor JM, Thomas KS, Akram P, et al. Home-based narrowband UVB, topical corticosteroid or combination for children and adults with vitiligo: HI-Light Vitiligo three-arm RCT. Health Technol Assess. 2020;24(64):1-128.
Castanedo-Cazares JP, Lepe V, Moncada B. Repigmentation of chronic vitiligo lesions by following tacrolimus plus ultraviolet-B-narrow-band. Photodermatol Photoimmunol Photomed. 2003;19(1):35-36.
Fai D, Cassano N, Vena GA. Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients. J Eur Acad Dermatol Venereol. 2007;21(7):916-920.
Nordal EJ, Guleng GE, Rönnevig JR. Treatment of vitiligo with narrowband-UVB (TL01) combined with tacrolimus ointment (0.1 %) vs. placebo ointment, a randomized right/left double-blind comparative study. J Eur Acad Dermatol Venereol. 2011;25(12):1440-1443.
Passeron T, Ostovari N, Zakaria W, et al. Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo. Arch Dermatol. 2004;140(9):1065-1069.
Phan K, Phan S, Shumack S, Gupta M. Repigmentation in vitiligo using Janus kinase (JAK) inhibitors with phototherapy: systematic review and Meta-analysis. J Dermatolog Treat. 2022;33(1):173-177.
Kreutz M, Karrer S, Hoffmann P, et al. Whole-body UVB irradiation during allogeneic hematopoietic cell transplantation is safe and decreases acute graft-versus-host disease. J Invest Dermatol. 2012;132(1):179-187.
Sorenson E, McAndrew R, Patel V, et al. Narrowband UV-B phototherapy for steroid-refractory sclerotic chronic cutaneous graft-vs-host disease. JAMA Dermatol. 2015;151(6):635-637.
George L, Peter D, Chopra M, et al. Efficacy of narrow band UVB in the treatment of cutaneous GvHD: an Indian experience. Bone Marrow Transplant. 2016;51(7):988-990.
Grundmann-Kollmann M, Martin H, Ludwig R, et al. Narrowband UV-B phototherapy in the treatment of cutaneous graft versus host disease. Transplantation. 2002;74(11):1631-1634.
Iyama S, Murase K, Sato T, et al. Narrowband ultraviolet B phototherapy ameliorates acute graft-versus-host disease by a mechanism involving in vivo expansion of CD4+ CD25+ Foxp3+ regulatory T cells. Int J Hematol. 2014;99(4):471-476.
Enk C, Elad S, Vexler A, et al. Chronic graft-versus-host disease treated with UVB phototherapy. Bone Marrow Transplant. 1998;22(12):1179-1183.
Schlaak M, Schwind S, Wetzig T, et al. UVA (UVA-1) therapy for the treatment of acute GVHD of the skin. Bone Marrow Transplant. 2010;45(12):1741-1748.
Connolly KL, Griffith JL, McEvoy M, Lim HW. Ultraviolet A1 phototherapy beyond morphea: experience in 83 patients. Photodermatol Photoimmunol Photomed. 2015;31(6):289-295.
Wolff D, Zeiser R, Scheid C, et al. Graft-versus-Host Erkrankung, chronisch. 2022. Available from: https://www.onkopedia.com/de/onkopedia/guidelines/graft-versus-host-erkrankung-chronisch/@@guideline/html/index.html [Last accessed February 24, 2023].
Zeiser R, Wolff D, Scheid C, et al. Graft-versus-Host Erkrankung, akut. 2022. Available from: https://www.onkopedia.com/de/onkopedia/guidelines/graft-versus-host-erkrankung-akut/@@guideline/html/index.html [Last accessed February 24, 2023].
Malewska-Woźniak A, Osmola-Mañkowska A, Adamski Z. Effectiveness of PUVA vs. UVA1 phototherapy in the treatment of morphea patients. Postepy Dermatol Alergol. 2022;39(4):757-761.
Kreuter A, Hyun J, Stücker M, et al. A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma. J Am Acad Dermatol. 2006;54(3):440-447.
Vasquez R, Jabbar A, Khan F, et al. Recurrence of morphea after successful ultraviolet A1 phototherapy: a cohort study. J Am Acad Dermatol. 2014;70(3):481-488.
Pavlotsky F, Sakka N, Lozinski A, Barzilai A. Bath psoralen - UVA photochemotherapy for localized scleroderma: experience from a single institute. Photodermatol Photoimmunol Photomed. 2013;29(5):247-252.
Stern RS. Study PF-U. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study. J Am Acad Dermatol. 2012;66(4):553-562.
Lim JL, Stern RS. High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients. J Invest Dermatol. 2005;124(3):505-513.
Archier E, Devaux S, Castela E, et al. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol. 2012;26:22-31.
Hearn RM, Kerr AC, Rahim KF, et al. Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy. Br J Dermatol. 2008;159(4):931-935.
Weischer M, Blum A, Eberhard F, et al. No evidence for increased skin cancer risk in psoriasis patients treated with broadband or narrowband UVB phototherapy: a first retrospective study. Acta Derm Venereol. 2004;84(5):370-374.
Raone B, Patrizi A, Gurioli C, et al. Cutaneous carcinogenic risk evaluation in 375 patients treated with narrowband-UVB phototherapy: A 15-year experience from our Institute. Photodermatol Photoimmunol Photomed. 2018;34(5):302-306.
Bae JM, Ju HJ, Lee RW, et al. Evaluation for skin cancer and precancer in patients with vitiligo treated with long-term narrowband UV-B phototherapy. JAMA Dermatol. 2020;156(5):529-537.
Bedair K, Elhadad A, Hamad S, et al. No association between whole-body ultraviolet A1 phototherapy and skin cancers in humans: A cancer registry linkage study. Br J Dermatol. 2020;183(3):586-587.
Stern RS, Nichols KT, Väkevä LH. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). N Engl J Med. 1997;336(15):1041-1045.
Lindelöf B, Sigurgeirsson B, Tegner E, et al. PUVA and cancer risk: the Swedish follow-up study. Br J Dermatol. 1999;141(1):108-112.
Hofbauer G. Phototherapie und Karzinogenese. Der Hautarzt. 2013;64(5):349-353.